The current study demonstrates that adjunctive TPE therapy in septic shock is not associated with the removal of proinflammatory cytokines but with the removal of inflammatory acute-phase proteins and immunosuppressive IL-2Rα/CD25, which may contribute to the rapid hemodynamic improvement recently observed in septic shock patients. The gene discussed is IL2RA; the disease is septic shock.